255 related articles for article (PubMed ID: 26482052)
1. Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?
Askenasy N
Immunol Res; 2016 Feb; 64(1):36-43. PubMed ID: 26482052
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.
Askenasy N
Immunol Res; 2016 Apr; 64(2):360-8. PubMed ID: 26639356
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of peripheral tolerance to islet antigens.
Hamilton-Williams EE; Bergot AS; Reeves PL; Steptoe RJ
J Autoimmun; 2016 Aug; 72():118-25. PubMed ID: 27255733
[TBL] [Abstract][Full Text] [Related]
4. Breakdown in peripheral tolerance in type 1 diabetes in mice and humans.
Jeker LT; Bour-Jordan H; Bluestone JA
Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007807. PubMed ID: 22393537
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.
Askenasy N
Immunology; 2016 Apr; 147(4):377-88. PubMed ID: 26749404
[TBL] [Abstract][Full Text] [Related]
8. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.
Geenen V; Mottet M; Dardenne O; Kermani H; Martens H; Francois JM; Galleni M; Hober D; Rahmouni S; Moutschen M
Curr Opin Pharmacol; 2010 Aug; 10(4):461-72. PubMed ID: 20434402
[TBL] [Abstract][Full Text] [Related]
9. How the immune system achieves self-nonself discrimination during adaptive immunity.
Jiang H; Chess L
Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
[TBL] [Abstract][Full Text] [Related]
10. Presentation of neuroendocrine self in the thymus: a necessity for integrated evolution of the immune and neuroendocrine systems.
Geenen V
Ann N Y Acad Sci; 2012 Jul; 1261():42-8. PubMed ID: 22823392
[TBL] [Abstract][Full Text] [Related]
11. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
12. A role for innate immunity in type 1 diabetes?
Beyan H; Buckley LR; Yousaf N; Londei M; Leslie RD
Diabetes Metab Res Rev; 2003; 19(2):89-100. PubMed ID: 12673777
[TBL] [Abstract][Full Text] [Related]
13. T regulatory cells in autoimmune diabetes: past challenges, future prospects.
Bluestone JA; Tang Q; Sedwick CE
J Clin Immunol; 2008 Nov; 28(6):677-84. PubMed ID: 18716861
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review.
Gupta S; Louis AG
Clin Rev Allergy Immunol; 2013 Oct; 45(2):162-9. PubMed ID: 23296947
[TBL] [Abstract][Full Text] [Related]
15. Thymic involution: implications for self-tolerance.
Hakim FT; Gress RE
Methods Mol Biol; 2007; 380():377-90. PubMed ID: 17876107
[TBL] [Abstract][Full Text] [Related]
16. Suppressor T cells--they're back and critical for regulation of autoimmunity!
Chatenoud L; Salomon B; Bluestone JA
Immunol Rev; 2001 Aug; 182():149-63. PubMed ID: 11722631
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations.
Capalbo D; Giardino G; Martino LD; Palamaro L; Romano R; Gallo V; Cirillo E; Salerno M; Pignata C
Int Rev Immunol; 2012 Oct; 31(5):344-62. PubMed ID: 23083345
[TBL] [Abstract][Full Text] [Related]
18. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells--the renaissance of the suppressor T cells.
Bopp T; Jonuleit H; Schmitt E
Ann Med; 2007; 39(5):322-34. PubMed ID: 17701475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
